Table 3

HRs for all-cause mortality out to 11-years follow-up in Western Australians aged 65–84 years during 1995–2006 with a first myocardial infarction as principal diagnosis

HRs for follow-up to 2006
Adjusted HR*
(95% CI) MEN
Adjusted HR*
(95% CI) WOMEN
Adjusted HR*,†
(95% CI) TOTAL
Preventive drugs dispensed within 28 days postdischarge
 NoneRefRefRef
 BB only0.88 (0.75 to 1.05)0.88 (0.70 to 1.10)0.90 (0.78 to 1.03)
 ST only0.78 (0.61 to 1.00)0.95 (0.72 to 1.26)0.86 (0.72 to 1.04)
 ACEi/ARB only1.23 (1.06 to 1.42)1.41 (1.19 to 1.68)1.30 (1.17 to 1.46)
 BB+ST0.46 (0.36 to 0.58)0.77 (0.60 to 0.99)0.58 (0.48 to 0.69)
 BB+ACEi/ARB0.82 (0.70 to 0.96)1.11 (0.91 to 1.37)0.92 (0.81 to 1.05)
 ST+ACEi/ARB0.90 (0.75 to 1.07)0.85 (0.68 to 1.08)0.89 (0.77 to 1.02)
 BB+ST+ACEi/ARB0.62 (0.53 to 0.73)0.69 (0.56 to 0.85)0.66 (0.58 to 0.75)
  • *Cox multivariate regression adjusted for age, previous IHD (within 5 years prior admission), previous heart failure (within 5 years prior admission), previous CARP (during hospitalisation or within 28 days of discharge or within 5 years prior admission), previous BB dispensed (with 2 months prior admission), previous statins dispensed (with 2 months prior admission), previous ACEi/ARB dispensed (with 2 months prior admission), aspirin and/or clopidogrel dispensed within 28 days postdischarge, Charlson index.

  • †Also adjusted for gender.

  • ACEi/ARB, angiotensin-converting-enzyme inhibitor/angiotensin II receptor blockers; BB, βblockers; CARP, coronary artery revascularisation procedure; IHD, ischaemic heart disease; ST, statins.